LTR Pharma (ASX:LTP) is a biopharmaceutical business focused on improving men’s physical and mental health by bringing to market the first nasal spray, SPONTAN, used to treat erectile dysfunction. LTR Pharma Executive Chairman, Lee Rodne joins The Stock Network’s Lel Smits.
1. Market problem and opportunity
Erectile dysfunction affects the quality of life for many men, making it a significant healthcare challenge around the world. Just how prevalent is this condition and how big is the market opportunity you are targeting with SPONTAN?
2. SPONTAN advantages over competitors
What are some of the drawbacks of existing treatments for erectile dysfunction and what advantages does SPONTAN present?
3. Commercialisation Push
You recently concluded a $25 million capital raise to progress the commercialisation of SPONTAN, both in Australia and the US. What deals have you already got in place to bring the product to market, and what milestones can we look forward to this year?
_ _ _
Subscribe to TSN’s YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1
_ _ _
Follow TSN for the latest stock news and interviews:
Twitter: https://twitter.com/thestocknet
Instagram: https://www.instagram.com/thestocknetwork/
LinkedIn: https://www.linkedin.com/company/the-stock-network/
TikTok: https://www.tiktok.com/@thestocknet?lang=en
Facebook: https://www.facebook.com/TheStockNet/
_ _ _
Connect with our host Lel Smits online – @LelSmits
– Twitter / X: https://twitter.com/lelsmits
– Instagram: https://www.instagram.com/lelsmits/
– LinkedIn: https://www.linkedin.com/in/leldesmits/
– TikTok: https://www.tiktok.com/@lelsmits?lang=en
– Facebook: https://m.facebook.com/lelsmits/
– Threads: https://www.threads.net/@lelsmits
_ _ _
Disclaimer
The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss.
This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer.
_ _ _
Visit TSN’s website to sign up for regular stock updates: https://www.thestocknetwork.com.au
_ _ _